- Home
- KROS vs THW Comparison
KROS vs THW Comparison
Compare KROS & THW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- THW
- Stock Information
- Founded
- KROS 2015
- THW 2015
- Country
- KROS United States
- THW United States
- Employees
- KROS N/A
- THW N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- THW Finance Companies
- Sector
- KROS Health Care
- THW Finance
- Exchange
- KROS Nasdaq
- THW Nasdaq
- Market Cap
- KROS 565.0M
- THW 478.4M
- IPO Year
- KROS 2020
- THW N/A
- Fundamental
- Price
- KROS $15.65
- THW $11.97
- Analyst Decision
- KROS Buy
- THW
- Analyst Count
- KROS 14
- THW 0
- Target Price
- KROS $20.56
- THW N/A
- AVG Volume (30 Days)
- KROS 445.6K
- THW 149.9K
- Earning Date
- KROS 11-05-2025
- THW 01-01-0001
- Dividend Yield
- KROS N/A
- THW 10.76%
- EPS Growth
- KROS N/A
- THW N/A
- EPS
- KROS 0.47
- THW N/A
- Revenue
- KROS $232,844,000.00
- THW N/A
- Revenue This Year
- KROS $5,579.44
- THW N/A
- Revenue Next Year
- KROS N/A
- THW N/A
- P/E Ratio
- KROS $33.59
- THW N/A
- Revenue Growth
- KROS 85820.30
- THW N/A
- 52 Week Low
- KROS $9.12
- THW $9.76
- 52 Week High
- KROS $72.37
- THW $14.89
- Technical
- Relative Strength Index (RSI)
- KROS 59.98
- THW 69.19
- Support Level
- KROS $15.25
- THW $11.62
- Resistance Level
- KROS $16.00
- THW $12.12
- Average True Range (ATR)
- KROS 0.61
- THW 0.14
- MACD
- KROS 0.03
- THW 0.01
- Stochastic Oscillator
- KROS 78.77
- THW 79.03
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About THW abrdn World Healthcare Fund Shares of Beneficial Interest
Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies engaged in the healthcare industry. The company's investment portfolio comprises investments in different sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other areas. It also male into REIT Real Estate.